Bicocca Open Archive

Logo unimib boa
VILLA, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.176
EU - Europa 2.627
AS - Asia 1.547
SA - Sud America 57
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 10.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.069
IT - Italia 712
SG - Singapore 634
DE - Germania 404
IE - Irlanda 344
HK - Hong Kong 342
SE - Svezia 304
CN - Cina 294
RU - Federazione Russa 275
UA - Ucraina 192
GB - Regno Unito 111
ID - Indonesia 110
CA - Canada 100
AT - Austria 71
FI - Finlandia 65
VN - Vietnam 56
BR - Brasile 49
DK - Danimarca 41
FR - Francia 36
IN - India 32
TR - Turchia 22
NL - Olanda 21
BE - Belgio 17
IL - Israele 12
IR - Iran 9
ES - Italia 5
EU - Europa 5
JP - Giappone 5
TW - Taiwan 5
UZ - Uzbekistan 5
MX - Messico 4
PL - Polonia 4
BG - Bulgaria 3
GR - Grecia 3
IQ - Iraq 3
KR - Corea 3
MA - Marocco 3
PK - Pakistan 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HU - Ungheria 2
MU - Mauritius 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.426
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.457
Fairfield 663
Woodbridge 518
Singapore 417
Houston 368
Wilmington 348
Hong Kong 340
Dublin 333
Frankfurt am Main 309
Ashburn 275
Chandler 269
Milan 262
Seattle 236
Cambridge 213
Jacksonville 179
Santa Clara 169
New York 150
Princeton 148
Jakarta 108
Dearborn 98
Altamura 89
Lawrence 68
Nanjing 67
Vienna 61
Ottawa 47
San Diego 42
Guangzhou 37
Beijing 36
Lachine 29
Fremont 28
Helsinki 28
Dong Ket 26
Grafing 24
Council Bluffs 22
Shanghai 20
Andover 19
Nanchang 17
Boardman 14
Brussels 14
Hebei 14
Los Angeles 14
Toronto 14
Chicago 13
Rome 13
Shenyang 13
Norwalk 12
Jiaxing 10
Kocaeli 9
London 9
Carate Brianza 8
Hyderabad 8
Paris 8
Tianjin 8
Edmonton 7
Falls Church 7
Fuzhou 7
Monza 7
Munich 7
Florence 6
Jinan 6
Kiev 6
Lappeenranta 6
Nuremberg 6
San Mateo 6
Bonndorf 5
Hefei 5
Kunming 5
Taizhou 5
Tashkent 5
Bergamo 4
Cinisello Balsamo 4
Dallas 4
Gambolò 4
Gessate 4
Kaohsiung 4
Marche 4
Melegnano 4
Modena 4
Naples 4
Napoli 4
Stezzano 4
São Paulo 4
Trento 4
Washington 4
Bareggio 3
Brescia 3
Busto Arsizio 3
Castiglione delle Stiviere 3
Changsha 3
Daejeon 3
Delhi 3
Detroit 3
Gelsenkirchen 3
Kardzhali 3
Kilburn 3
Lyngby 3
Maniago 3
Pavia 3
Phoenix 3
Pianoro 3
Totale 7.905
Salva come PNG Salva come JPEG
Nome #
CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation 371
Analysis of human papillomavirus (HPV) 16 variants associated with cervical infection in Italian women 321
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 296
Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update 246
Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy 243
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 242
Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing 242
Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE) 231
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 227
The synergistic relationship between Alzheimer's disease and sleep disorders: An update 222
Variants in CHRNB2 and CHRNA4 identified in patients with insular epilepsy 222
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges 218
Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease 207
Potassium channels and human epileptic phenotypes: An updated overview 200
Genetic architecture and molecular, imaging and prodromic markers in dementia with lewy bodies: State of the art, opportunities and challenges 174
Circulating miRNAs as potential biomarkers in Alzheimer’s disease 161
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder 157
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 156
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms 155
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 154
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis 152
GSK3β genetic variability in patients with Multiple Sclerosis 149
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 148
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis 148
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 146
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease 143
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation 142
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 140
Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia 139
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder 137
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder 135
Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype 135
Candidate gene analysis of selectin cluster in patients with multiple sclerosis 134
C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia 133
A novel role of cardiac inwardly rectifying potassium channels explaining autonomic cardiovascular dysfunctions in a cuprizone-induced mouse model of multiple sclerosis 131
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 125
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration 124
Immunoreactivity of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and kir channels in a model of epilepsy 124
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 122
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 119
Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson’s disease: Molecular mechanisms connecting neuroinflammation to α-synuclein spreading pathology 118
Causal Frontotemporal Lobar Degeneration mutations: a novel MAPT mutation associated with the clinical phenotype of Progressive nonfluent Aphasia 116
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 114
FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration 114
Ehlers-Danlos syndromes and epilepsy: An updated review 112
Epileptic seizures in autosomal dominant forms of Alzheimer's disease 111
Unraveling the role of inwardly rectifying potassium channels in the hippocampus of an Aβ(1-42)-infused rat model of Alzheimer's disease 111
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with alzheimer's disease 111
Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration? 104
Investigating cardiac morphological alterations in a pentylenetetrazol-kindling model of epilepsy 104
GRN variability contributes to sporadic frontotemporal lobar degeneration 102
C9ORF72 repeat expansion is not detected in patients with multiple sclerosis 101
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 100
The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype 98
Genetics and expression analysis of Sp4 transcription factor in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 96
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 96
Circulating miRNAs as potential biomarkers in Alzheimer's disease 95
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration 95
Novel exon 1 progranulin gene variant in Alzheimer's disease 86
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 86
MCP-1 A-2518G polymorphism: Effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels 85
Causal frontotemporal lobar degeneration mutations: a novel mutation in MAPT associated with non-fluent progressive aphasia phenotype 80
Transcription factor Sp1 is regulated by hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 79
CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration 79
Exome Sequencing in an ADSHE Family: VUS Identification and Limits 78
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 78
Arylsulfatase a (Asa) in parkinson’s disease: From pathogenesis to biomarker potential 73
A 45-year-old Italian male with p.(Gly1815Ser) FBN1 mutation causing a mild variant of Marfan syndrome: A case study 72
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration 66
Tlr-mediated signal transduction and neurodegenerative disorders 66
Biomarkers for alzheimer’s disease: Where do we stand and where are we going? 65
Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis 61
Multi-omics for the understanding of brain diseases 61
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 59
Microfluidic platforms to unravel mysteries of alzheimer’s disease: How far have we come? 59
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 56
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects 56
Epigenetics in Alzheimer’s Disease: A Critical Overview 53
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease 52
Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer’s Disease 51
Psychosis in Parkinson’s Disease: A Lesson from Genetics 50
Expression and genetic analysis of microRNAs involved in multiple sclerosis 48
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments 46
Ocular vascular changes: Choroidal thickness as an early biomarker for Alzheimer’s disease? 42
Edaravone: A Novel Possible Drug for Cancer Treatment? 38
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders 37
Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics 33
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders 32
Insights into Dysregulated Neurological Biomarkers in Cancer 32
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases 20
Blood-based biomarkers in mild behavioral impairment: an updated overview 10
Totale 10.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020262 0 0 0 0 0 0 0 0 0 102 114 46
2020/20212.102 104 234 190 217 145 194 148 188 146 191 152 193
2021/20221.208 148 150 160 100 82 135 60 55 45 40 77 156
2022/20231.497 188 436 149 93 89 244 15 78 111 26 44 24
2023/20241.146 44 41 35 111 123 273 179 34 137 18 20 131
2024/20251.921 165 379 184 143 260 134 103 109 424 20 0 0
Totale 10.958